Condition

cGVHD clinical trials and research

• 7Clinical trials
• 2Countries

Newest cGVHD clinical trials

All recruiting trials (7)

• Belumosudil vs. Ruxolitinib for hepatic cGVHD after HSCT

  This trial tests whether belumosudil or ruxolitinib works better for hepatic chronic GVHD after a stem cell transplant in people 12 and older.

  Recruiting First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT07794514

• GT729 universal cell injection for refractory or relapsed chronic graft-versus-host disease

  This trial will try GT729 universal cell injections in adults whose chronic graft-versus-host disease has not responded to at least two prior systemic treatments after an allogeneic stem cell transplant.

  Recruiting Early Phase 1 Grit Biotechnology · Tianjin, Tianjin Municipality · NCT07253259

• BPC2001 to prevent acute graft-versus-host disease after haploidentical stem cell transplant

  This trial tests whether six weekly doses of BPC2001 given with standard care can prevent acute graft-versus-host disease in adults having haploidentical stem cell transplants.

  Recruiting at 2 sites Phase 2 BioPhoenix Co., Ltd. · Beijing, Beijing Municipality and 1 other locations · NCT07246031

• Donor-derived regulatory T cell infusion with interleukin-2 for refractory chronic GVHD

  This will try infusing donor-derived regulatory T cells together with low-dose recombinant interleukin-2 in adults with steroid-refractory or steroid-dependent chronic graft-versus-host disease.

  Recruiting Early Phase 1 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai · NCT06920199

• Combination treatment for chronic Graft-versus-Host Disease

  This study is testing a new combination treatment with Axatilimab and light therapy to see if it helps people with chronic Graft-versus-Host Disease who haven't responded well to other treatments.

  Recruiting at 3 sites Phase 2 University of Miami · San Francisco, California and 2 other locations · NCT06663722

• Using Iguratimod to treat chronic graft-versus-host disease

  This study is testing if Iguratimod, a medication usually for rheumatoid arthritis, can help people with chronic graft-versus-host disease feel better and improve their lung function.

  Recruiting Phase 1/2 Xuzhou Medical University · Xuzhou, Jiangsu · NCT06244628

• Observational study for patients at risk of chronic graft-versus-host disease

  This study is tracking the health of people who have recently had a stem cell transplant to see if they develop chronic graft-versus-host disease over the next few months.

  Recruiting at 36 sites Incyte Corporation · Birmingham, Alabama and 36 other locations · NCT05919511

Related topics

Quick answers

How many cGVHD clinical trials are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in China (5 trials), United States (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Early Phase 1: 2, Phase 2: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →